Results 251 to 260 of about 339,218 (339)

An insight into the draft genome of the Oriental rat flea, Xenopsylla cheopis, together with its Wolbachia endosymbiont. [PDF]

BMC Genomics
Lu S, Bland DM, Dahlstrom E, Redekar N, Guizzo MG, Barbian K, Hinnebusch BJ, Ribeiro JMC.   +7 more
europepmc   +1 more source

IDENTIFICATION BY ISOTOPIC SUBSTITUTION OF THE EPR SIGNAL AT g = 1.94 IN A NON-HEME IRON PROTEIN FROM AZOTOBACTER

, 1964
Y. I. Shethna, P. W. Wilson, Raymond E. Hansen, Helmut Beinert   +3 more
openalex   +1 more source

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

ESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai, Minoru Yasukawa, Shigeru Shibata   +2 more
wiley   +1 more source

Increased calcification by erythrophagocytosis in aortic valvular interstitial cells

ESC Heart Failure, Volume 12, Issue 2, Page 1469-1473, April 2025.
Abstract Background Calcific aortic valve disease (CAVD) progresses over time to severe aortic stenosis and eventually heart failure. Recent evidence indicates that intraleaflet haemorrhage (ILH) strongly promotes CAVD progression. However, it remains poorly understood how it mechanistically contributes to valvular calcification.
Zihan Qin, Magnus Bäck, Anders Franco‐Cereceda, Sven‐Christian Pawelzik   +3 more
wiley   +1 more source

Interaction of Nitrogenous Ligands with Heme Peptides from Mammalian Cytochrome c

, 1960
Henry A. Harbury, Paul A. Loach
openalex   +1 more source

Lon-dependent proteolysis in oxidative stress responses. [PDF]

J Bacteriol
Yigit K, Chien P.
europepmc   +1 more source

Studies on the Oxidation-Reduction Potentials of Heme Proteins

, 1967
Maurizio Brunori, John Fuller Taylor, Eraldo Antonini, Jeffries Wyman, A. Rossi‐Fanelli   +4 more
openalex   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Unveiling the role of erinacines in the neuroprotective effects of <i>Hericium erinaceus</i>: a systematic review in preclinical models. [PDF]

Front Pharmacol
Spangenberg ET, Moneypenny A, Bozzo GG, Perreault ML.   +3 more
europepmc   +1 more source

The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

European Journal of Heart Failure, EarlyView.
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg, Ridha I.S. Alnuwaysir, George Markousis‐Mavrogenis, Martijn F. Hoes, Haye H. van der Wal, Simon P.R. Romaine, Mintu Nath, Andrea Koekoemoer, John G.F. Cleland, Chim C. Lang, Stefan D. Anker, Kenneth Dickstein, Marco Metra, Leong L. Ng, Dirk J. van Veldhuisen, Adriaan A. Voors, Nilesh J. Samani, Peter van der Meer   +17 more
wiley   +1 more source